Loading
Latest filing published 14 Mar 2022 for Mydecine Innovations Group Inc..
No signal scores available.
Robert Fletcher Roscow discloses dealings in Mydecine Innovations Group Inc. to SEDI. We count 2 filings, every one of them for a trade on 30 April 2020.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 14 March 2022 came the latest disclosure, a transaction in Mydecine Innovations Group Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations